Wednesday, November 25, 2009, 4:32am SGT - The Singapore stock market opens in 4 hours and 28 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Vision-Sciences Inc. (VSCI)

At 4:15AM SGT: 1.09 USD  Down 0.18 (14.17%)  
 MORE ON VSCI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Vision-Sciences, Inc. (NCM:VSCI) Delayed quote dataEdit
Last Trade:1.09 USD
Trade Time:4:15AM SGT
Change:Down 0.18 (14.17%)
Prev Close:1.27
Open:1.21
Bid:1.10 x 5000
Ask:1.21 x 200
1y Target Est:5.00
Day's Range:1.09 - 1.30
52wk Range:0.75 - 2.74
Volume:23,948
Avg Vol (3m):56,812.3
Market Cap:40.17M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add VSCI to Portfolio   Download Data

 HEADLINES 
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed 3:27am)
•VISION SCIENCES INC /DE/ Financials
EDGAR Online Financials (Wed, Nov 18)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Fri, Nov 13)
•Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010
GlobeNewswire (Fri, Nov 13)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
EDGAR Online (Fri, Nov 13)
•Vision-Sciences, Inc. Does Not Satisfy Nasdaq's Requirement to Maintain a Majority of Independent Directors
GlobeNewswire (Fri, Nov 13)
•Q2 2010 Vision-Sciences, Inc. Earnings Release - After Market Close
CCBN (Thu, Nov 12)
•Vision-Sciences, Inc. Appoints Warren Bielke Interim Chief Executive Officer
GlobeNewswire (Mon, Nov 9)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Oct 22)
•VISION SCIENCES INC /DE/ Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Thu, Aug 20)
More Headlines for VSCI...
 ANALYST 
EPS Est (next year) (Mar-10) :N/A
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Vision-Sciences, Inc. engages in the design, development, manufacture, and marketing of endoscopy products. The company operates through two segments, Medical and Industrial.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices